logo
logo
Sign in

COVID-19 Impact on the Animal Health Market

avatar
Nilkanth Rathod
COVID-19 Impact on the Animal Health Market

Coronavirus has spread across 215 countries and territories and affected more than 4.4 million people, with close to 300 thousand deaths. The pandemic has had considerable social and economic ramifications across a variety of industries and sectors. As of 28 October 2020, there have been 44,235,263 reported cases of COVID-19 (Source: Worldometer) from Africa, Asia Pacific, the Americas, Europe, and Oceania. 

The virus has resulted in 1,171,288 deaths. The true number of infected people would be much higher than the official total, as a large number of cases are asymptomatic and do not undergo testing. It could be assumed that there is a drastic change in the size of the APAC animal health market. 

In this scenario, the major end-user segment for APAC animal health, namely, veterinary hospitals & clinics, animal farms, and homecare settings, are expected to be moderately impacted. This could be attributed to the scarcity of trade and transport restrictions, which are expected to recover gradually in Q4 of 2020 as trade relations in most countries achieve near-normalcy. 

The prevalence of obesity has increased more than twofold since 1980. According to a journal published by Development Asia in 2018, two of five adults in the Asia Pacific region are found to be overweight or obese, and it is considered to be home to the largest absolute number of obese people, about 1 billion.

The prevalence of obesity in the Asia Pacific ranges from less than 5% in India to 60% in Australia. Although the prevalence in China is a third of that in Australia, the increase in prevalence in China over the last 20 years was 400% compared to 20% in Australia.

For More Information Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=106215485 

 Rapid urbanization and growing disposable incomes are some of the key factors driving pet ownership in these countries. Many pet owners in these countries are now willing to spend more on pet care, specifically healthcare services.

These countries have robust livestock markets. According to a Dairy Tech India article, India is emerging as the world's second-largest poultry market, with an annual growth of more than 14%. India is the world's largest milk producer. According to the US Meat Export Federation, China ranks first in the world for pork consumption. The consumption of pork increased from 28.3 kg per person in 2012 to 34.2 kg per person in 2019.

the APAC animal health market is segmented into parasiticides, antimicrobials and antibiotics, vaccines, feed additives/nutritional products, growth promoters, and other pharmaceuticals. Vaccines are expected to have the highest growth rate during the forecast period due to the growing prevalence of animal-related diseases in Asian countries.

The food-producing animals had the largest share, by an animal, in 2019.

Based on animals, the APAC animal health market is categorized into food-producing animals and companion animals. In 2019, food-producing animals accounted for a large share of the APAC animal health market. The larger share of this segment is due to the increasing livestock population and rising demand for animal-derived food products.

Animal Farms are the largest end-user segment of the APAC Animal Health market.

Based on end-user, the market has been classified into veterinary hospitals & clinics, animal farms, and homecare. In 2019, the animal farms segment accounted for the largest market share of the APAC animal health market. This is because of the large population of livestock in emerging Asia Pacific countries, growing demand for animal-derived food products, and rising incidences of zoonotic diseases. 

Recent Developments

  • In July 2020, Boehringer Ingelheim launched an external innovation hub in China.
  • In July 2020, Merck acquired the US rights from Virbac for the SENTINEL brand of combination parasiticides used to protect dogs against fleas and common intestinal parasites.
  • In July 2020, Zoetis announced a collaboration with Trianni for the development of transgenic monoclonal antibody platforms for the discovery of new veterinary treatments
  • In April 2020, Elanco collaborated with VetNow to provide relief to veterinarians by expanding its products and service access through the telemedicine platform.
  • In July 2017, Zoetis completed the acquisition of Nexvet, a biologic therapeutics company.
collect
0
avatar
Nilkanth Rathod
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more